Andy Tompkins, MD, MHS
Professor
Psychiatry
School of Medicine
Education & Training
Show all (6) Hide
- MHS Clinical Investigation Johns Hopkins Bloomberg School of Public Health 08/2014
- Post-doctoral Fellowship Behavioral Pharmacology / Addictions Johns Hopkins University School of Medicine 06/2010
- Residency Psychiatry Johns Hopkins Hospital 06/2008
- Internship Psychiatry-Medicine Johns Hopkins Bayview Medical Center 06/2005
- MD Medicine New York Medical College 05/2004
- BS Biology / English Emory University 05/1999
Websites
Show all (1) Hide
- DSAAM's Website (dsaam.org)
Grants and Projects
Show all (14) Hide
- Project JUNO Community (JUstice-iNvolved Opioid use disorder treatment engagement in Community), SAMHSA, 2021-2026
- Western States Node of the National Drug Abuse Treatment Clinical Trials Network, NIH, 2002-2025
- Project HOUDINI LINK: Hospital Opioid Use Disorder treatment Initiation and LINKage to care, SAMHSA, 2018-2021
- The Effect of Chronic Pain on Delay Discounting in Methadone Patients, NIH, 2019-2021
- Using Cannabinoids to Enhance Opioid Analgesic Effects in Humans, NIH, 2016-2021
- Opioid and cannabinoid combinations in laboratory and clinical pain, NIH, 2017-2020
- Improving the Opioid Treatment Outpatient Program (OTOP) through the Addition of Yoga Therapy, San Francisco General Hospital Foundation, 2018-2019
- Mechanisms of Sleep Disruption Hyperalgesia, NIH, 2012-2018
- Role of Sleep in the Treatment of Cannabis Dependence, NIH, 2012-2017
- Optimizing Pain Treatment while Reducing Abuse Liability in Opioid Dependence, NIH, 2012-2017
- Multisite Controlled Trial of Cocaine Vaccine (3 of 6) Baltimore Treatment Site, NIH, 2008-2013
- Clinical Trial of Topiramate for Cocaine Addiction, NIH, 2006-2012
- Human Behavioral Pharmacology of Substance Abuse, NIH, 1981-2011
- Human Behavioral Pharmacology of Substance Abuse, NIH, 1981-2011
Publications (45)
Top publication keywords:
MeditationNarcotic AntagonistsOpioid-Related DisordersVital SignsHyperalgesiaSubstance Withdrawal SyndromePain ThresholdChronic PainAnalgesics, OpioidNaltrexoneBuprenorphineHydromorphoneYogaOpiate Substitution TreatmentMorphine
-
Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder.
Journal of substance use and addiction treatment 2023 Lee DC, Schlienz NJ, Herrmann ES, Martin EL, Leoutsakos J, Budney AJ, Smith MT, Tompkins DA, Hampson AJ, Vandrey R -
Substance Use in the Performing Artist with Chronic Pain.
Medical problems of performing artists 2022 Hay KR, Jardot J, Huhn AS, Tompkins DA -
"I got a bunch of weed to help me through the withdrawals": Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums.
PloS one 2022 Meacham MC, Nobles AL, Tompkins DA, Thrul J -
Assessing the Acceptability of Yoga Among Patients with and without Chronic Pain Enrolled in a Licensed Opioid Treatment Program.
International journal of yoga therapy 2022 Ahmadi E, Evans C, Agin-Liebes G, Tompkins DA -
A Qualitative Investigation Into Faith and LGBTQ Identities in a Nonclinical Sample of Readers of the Dear Abby Column: The Dear Abby Project.
The Journal of nervous and mental disease 2021 Ghazzawi A, Casoy F, Libby N, McIntosh C, Barber M, Adelson S, Ahola J, Ashley K, Chavez AM, Erickson-Schroth L, Fadus M, Goldenberg D, Hung K, Lothwell L, Mattson M, McAfee SG, Nowaskie DZ, Schwartz …
Show all (40 more) Hide
-
National trends in testing for hepatitis C virus in licensed opioid treatment programs: Differences by facility ownership and state medicaid expansion status.
Drug and alcohol dependence 2021 Pro G, Tompkins DA, Azari S, Zaller N -
Methadone maintenance patients lack analgesic response to a cumulative intravenous dose of 32 mg of hydromorphone.
Drug and alcohol dependence 2021 Agin-Liebes G, Huhn AS, Strain EC, Bigelow GE, Smith MT, Edwards RR, Gruber VA, Tompkins DA -
Experimental sleep disruption attenuates morphine analgesia: findings from a randomized trial and implications for the opioid abuse epidemic.
Scientific reports 2020 Smith MT, Mun CJ, Remeniuk B, Finan PH, Campbell CM, Buenaver LF, Robinson M, Fulton B, Tompkins DA, Tremblay JM, Strain EC, Irwin MR -
Religious faith and transgender identities: The Dear Abby project
Journal of Gay & Lesbian Mental Health 2020 Alhasan Ghazzawi, Selena Suhail-Sindhu, Flávio Casoy, Naomi Libby, Christopher A. McIntosh, Stewart Adelson, Kenneth Ashley, Jack Drescher, David Goldenberg, Kenneth Hung, Lorraine E. Lothwell, Marlin… -
Individuals with Chronic Pain Who Misuse Prescription Opioids Report Sex-Based Differences in Pain and Opioid Withdrawal.
Pain medicine (Malden, Mass.) 2019 Huhn AS, Tompkins DA, Campbell CM, Dunn KE -
The relationship between pupil diameter and other measures of opioid withdrawal during naloxone precipitated withdrawal.
Drug and alcohol dependence 2019 Bergeria CL, Huhn AS, Tompkins DA, Bigelow GE, Strain EC, Dunn KE -
Recovery Goals and Long-term Treatment Preference in Persons Who Engage in Nonmedical Opioid Use.
Journal of addiction medicine 2019 Hay KR, Huhn AS, Tompkins DA, Dunn KE -
Sex differences in measures of central sensitization and pain sensitivity to experimental sleep disruption: implications for sex differences in chronic pain.
Sleep 2019 Smith MT, Remeniuk B, Finan PH, Speed TJ, Tompkins DA, Robinson M, Gonzalez K, Bjurstrom MF, Irwin MR -
Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals.
Anesthesiology 2019 Huhn AS, Strain EC, Bigelow GE, Smith MT, Edwards RR, Tompkins DA -
Extended-release injectable naltrexone (XR-NTX): a response to clinical issues raised by Brewer & Streel.
Addiction (Abingdon, England) 2018 Jarvis BP, Holtyn AF, Subramaniam S, Tompkins DA, Oga EA, Bigelow G, Silverman K -
Prefrontal cortex response to drug cues, craving, and current depressive symptoms are associated with treatment outcomes in methadone-maintained patients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2018 Huhn AS, Sweeney MM, Brooner RK, Kidorf MS, Tompkins DA, Ayaz H, Dunn KE -
A hidden aspect of the U.S. opioid crisis: Rise in first-time treatment admissions for older adults with opioid use disorder.
Drug and alcohol dependence 2018 Huhn AS, Strain EC, Tompkins DA, Dunn KE -
Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes.
Addiction biology 2018 Dunn KE, Weerts EM, Huhn AS, Schroeder JR, Tompkins DA, Bigelow GE, Strain EC -
Psychiatric Disorders and Comorbid Cannabis Use: When Should We Be Concerned and What Can We Do About It?
The Journal of clinical psychiatry 2018 Satre DD, Borsari B, Tompkins DA, Ramo D -
Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial.
Drug and alcohol dependence 2018 Bisaga A, Mannelli P, Yu M, Nangia N, Graham CE, Tompkins DA, Kosten TR, Akerman SC, Silverman BL, Sullivan MA -
Extended-release injectable naltrexone for opioid use disorder: a systematic review.
Addiction (Abingdon, England) 2018 Jarvis BP, Holtyn AF, Subramaniam S, Tompkins DA, Oga EA, Bigelow GE, Silverman K -
Tramadol Extended-Release and Opioid Withdrawal Management-Legal Implications-Reply.
JAMA psychiatry 2018 Dunn KE, Tompkins DA, Strain EC -
The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use.
Drug and alcohol dependence 2017 Huhn AS, Tompkins DA, Dunn KE -
Ethnic Differences in the Effects of Naloxone on Sustained Evoked Pain: A Preliminary Study.
Diversity and equality in health and care 2017 Burton EF, Suen SY, Walker JL, Bruehl S, Peterlin BL, Tompkins DA, Buenaver LF, Edwards RR, Campbell CM -
Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.
JAMA psychiatry 2017 Dunn KE, Tompkins DA, Bigelow GE, Strain EC -
To take or not to take: the association between perceived addiction risk, expected analgesic response and likelihood of trying novel pain relievers in self-identified chronic pain patients.
Addiction (Abingdon, England) 2017 Tompkins DA, Huhn AS, Johnson PS, Smith MT, Strain EC, Edwards RR, Johnson MW -
Providing chronic pain management in the "Fifth Vital Sign" Era: Historical and treatment perspectives on a modern-day medical dilemma.
Drug and alcohol dependence 2017 Tompkins DA, Hobelmann JG, Compton P -
Pain catastrophizing may moderate the association between pain and secondary hyperalgesia.
Journal of applied biobehavioral research 2017 Pressman AJ, Peterlin BL, Tompkins DA, Salas RE, Buenaver LF, Haythornthwaite JA, Campbell CM -
Temporal preference in individuals reporting chronic pain: discounting of delayed pain-related and monetary outcomes.
Pain 2016 Tompkins DA, Johnson PS, Smith MT, Strain EC, Edwards RR, Johnson MW -
The Growing Regulation of Conversion Therapy.
Journal of medical regulation 2016 Drescher J, Schwartz A, Casoy F, McIntosh CA, Hurley B, Ashley K, Barber M, Goldenberg D, Herbert SE, Lothwell LE, Mattson MR, McAfee SG, Pula J, Rosario V, Tompkins DA -
Recruitment techniques for alcohol pharmacotherapy clinical trials: A cost-benefit analysis.
Addictive disorders & their treatment 2015 Tompkins DA, Sides JA, Harrison JA, Strain EC -
Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients.
Drug and alcohol dependence 2015 Dunn KE, Finan PH, Tompkins DA, Fingerhood M, Strain EC -
Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies.
Gynecologic oncology 2014 Liao C, Zhang D, Mungo C, Tompkins DA, Zeidan AM -
Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial.
Drug and alcohol dependence 2014 Umbricht A, DeFulio A, Winstanley EL, Tompkins DA, Peirce J, Mintzer MZ, Strain EC, Bigelow GE -
Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial.
Drug and alcohol dependence 2014 Kosten TR, Domingo CB, Shorter D, Orson F, Green C, Somoza E, Sekerka R, Levin FR, Mariani JJ, Stitzer M, Tompkins DA, Rotrosen J, Thakkar V, Smoak B, Kampman K -
The effect of repeated intramuscular alfentanil injections on experimental pain and abuse liability indices in healthy males.
The Clinical journal of pain 2014 Tompkins DA, Smith MT, Bigelow GE, Moaddel R, Venkata SL, Strain EC -
A double blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphine.
The Journal of pharmacology and experimental therapeutics 2013 Tompkins DA, Smith MT, Mintzer MZ, Campbell CM, Strain EC -
Opioid abusers' ability to differentiate an opioid from placebo in laboratory challenge testing.
Drug and alcohol dependence 2013 Antoine DG, Strain EC, Tompkins DA, Bigelow GE -
Report of the American Psychiatric Association Task Force on Treatment of Gender Identity Disorder.
Archives of sexual behavior 2012 Byne W, Bradley SJ, Coleman E, Eyler AE, Green R, Menvielle EJ, Meyer-Bahlburg HF, Pleak RR, Tompkins DA, American Psychiatric Association Task Force on Treatment of Gender Identity Disorder -
Treatment of gender identity disorder.
The American journal of psychiatry 2012 Byne W, Bradley SJ, Coleman E, Eyler AE, Green R, Menvielle E, Meyer-Bahlburg HF, Pleak RR, Tompkins DA -
Opioid-induced hyperalgesia: clinically relevant or extraneous research phenomenon?
Current pain and headache reports 2011 Tompkins DA, Campbell CM -
Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone.
Psychopharmacology 2010 Tompkins DA, Lanier RK, Harrison JA, Strain EC, Bigelow GE -
Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument.
Drug and alcohol dependence 2009 Tompkins DA, Bigelow GE, Harrison JA, Johnson RE, Fudala PJ, Strain EC -
Hematological adverse events in clozapine-treated children and adolescents.
Journal of the American Academy of Child and Adolescent Psychiatry 2005 Gerbino-Rosen G, Roofeh D, Tompkins DA, Feryo D, Nusser L, Kranzler H, Napolitano B, Frederickson A, Henderson I, Rhinewine J, Kumra S -
Phenotypic screening of mutations in Pmr1, the yeast secretory pathway Ca2+/Mn2+-ATPase, reveals residues critical for ion selectivity and transport.
The Journal of biological chemistry 2000 Wei Y, Chen J, Rosas G, Tompkins DA, Holt PA, Rao R